{
    "N/R/U": null,
    "Applicant": "Sanofi Pasteur Inc.",
    "BLA Number": "125682",
    "Proprietary Name": "Dengvaxia",
    "Proper Name": "Dengue Tetravalent Vaccine, Live",
    "BLA Type": "351(a)",
    "Strength": "4.5-6.0 LOG10 CCID50 CCID50: CELL CULTURE INFECTIOUS DOSE 50",
    "Dosage Form": "For Injection",
    "Route of Administration": "Subcutaneous",
    "Product Presentation": "Single-Dose Vial",
    "Marketing Status": "Rx",
    "Licensure": "Licensed",
    "Approval Date": "May 01, 2019",
    "Ref. Product Proper Name": " ",
    "Ref. Product Proprietary Name": null,
    "Supplement Number": "0",
    "Submission Type": "Original",
    "License Number": "1725",
    "Product Number": "001",
    "Center": "CBER",
    "Date of First Licensure": "May 01, 2019",
    "Exclusivity Expiration Date": null,
    "First Interchangeable Exclusivity Exp. Date": null,
    "Ref. Product Exclusivity Exp. Date": "May 01, 2031",
    "Orphan Exclusivity Exp. Date": null
}